Targeted Organs/Cells
DMG-PEG2000-MG1 is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an MG1 (HY-P11315) peptide as a terminal targeting/functional ligand. DMG-PEG2000-MG1 can be used in research on targeted drug delivery for neuroinflammation.
DMG-PEG2000-NGR (DMG-PEG2000-Mal-Cys-NGR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an NGR (HY-P1043) peptide as a terminal targeting/functional ligand. DMG-PEG2000-NGR can be used for tumor angiogenesis-targeted drug delivery.
DSG-PEG2000-GRGDS (DSG-PEG2000-Mal-Cys-GRGDS) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a Gly-Arg-Gly-Asp-Ser (GRGDS) (HY-P0295) peptide as a terminal targeting/functional ligand. DSG-PEG2000-GRGDS can be used in research on tumor-targeted drug delivery.
DSG-PEG2000-APRPG (DSG-PEG2000-Mal-Cys-APRPG) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an APRPG peptide as a terminal targeting/functional ligand. DSG-PEG2000-APRPG can be used in research on tumor angiogenesis-targeted drug delivery.
DMG-PEG2000-KAA (DMG-PEG2000-Mal-CKAAKNK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a KAA peptide as a terminal targeting/functional ligand. DMG-PEG2000-KAA can be used in research on targeted drug delivery for pancreatic tumors.
DMG-PEG2000-MTP (DMG-PEG2000-Mal-Cys-ASSLNIA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an MTP (HY-P10643) peptide as a terminal targeting/functional ligand. DMG-PEG2000-MTP can be used in research on muscle-targeted drug delivery and muscle tissue gene delivery.
DMG-PEG2000-Asp6 (DMG-PEG2000-Mal-Cys-DDDDDD) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an Asp6 peptide as a terminal targeting/functional ligand. DMG-PEG2000-Asp6 can be used in research such as bone-targeted drug delivery.
DSG-PEG2000-KAA (DSG-PEG2000-Mal-CKAAKNK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a KAA peptide as a terminal targeting/functional ligand. DSG-PEG2000-KAA can be used in research on targeted drug delivery for pancreatic tumors.
DSG-PEG2000-CTT2 is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the CTT2 peptide as a terminal targeting/functional ligand. DSG-PEG2000-CTT2 can be used in research on targeted drug delivery to the tumor microenvironment.
DMG-PEG2000-F3 (DMG-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an F3 (HY-P10997) peptide as a terminal targeting/functional ligand. DMG-PEG2000-F3 can be used in research such as tumor-targeted drug delivery.
DSG-PEG2000-PP1 (DSG-PEG2000-Mal-Cys-LSLERFLRCWSDAPA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a PP1 (HY-P12012) peptide as a terminal targeting/functional ligand. DSG-PEG2000-PP1 can be used in research on targeted drug delivery for atherosclerosis.
DSG-PEG2000-TAASGVRSMH (DSG-PEG2000-Mal-Cys-TAASGVRSMH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the TAASGVRSMH (HY-P10989) peptide as a terminal targeting/functional ligand. DSG-PEG2000-TAASGVRSMH can be used in research on tumor-targeted drug delivery, among other applications.
DSG-PEG2000-NYZL1 (DSG-PEG2000-Mal-Cys-NYZL1) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and the NYZL1 peptide as a terminal targeting/functional ligand. DSG-PEG2000-NYZL1 can be used in research on targeted drug delivery for bladder cancer, among other applications.
DMG-PEG2000-VIP (DMG-PEG2000-Mal-Cys-HSDAVFTDNYTRLRKQMAVKKYLNSILN) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a VIP peptide as a terminal targeting/functional ligand. DMG-PEG2000-VIP can be used in research such as targeted drug delivery for breast cancer.
DSG-PEG2000-VHPKQHRGGSKGC is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a VHPKQHRGGSKGC (HY-P11088A) peptide as a terminal targeting/functional ligand. DSG-PEG2000-VHPKQHRGGSKGC can be used in research on targeted drug delivery in inflammation, tumor angiogenesis, and atherosclerosis.
DSG-PEG2000-CGKRK (DSG-PEG2000-Mal-Cys-CGKRK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CGKRK peptide as a terminal targeting/functional ligand. DSG-PEG2000-CGKRK can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.
DSG-PEG2000-ESBP (DSG-PEG2000-Mal-Cys-DITWDQLWDLMK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an ESBP peptide as a terminal targeting/functional ligand. DSG-PEG2000-ESBP can be used in research such as targeted drug delivery for inflammation.
DMG-PEG2000-TH (DMG-PEG2000-Mal-Cys-TH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a TH peptide as a terminal targeting/functional ligand. DMG-PEG2000-TH can be used in studies of tumor microenvironment-responsive drug delivery.
DMG-PEG2000-CRPPR is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CRPPR (HY-P10641A) peptide as a terminal targeting/functional ligand. DMG-PEG2000-CRPPR can be used in studies of cardiac-targeted drug delivery.
DSG-PEG2000-A7R (DSG-PEG2000-Mal-Cys-ATWLPPR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an A7R (HY-P1663) peptide as a terminal targeting/functional ligand. DSG-PEG2000-A7R can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.
